- 4 health system marketing leaders on what actually builds patient trust
- How a $2.9B health system grew brand awareness from 7% to 36%
- Building ASCs in a cost-vs-reimbursement squeeze: 4 takeaways for surgery center leaders
- Dentistry’s pay conundrum
- California hospital names interim CEO
- 2 healthcare workforce lobbying pushes to watch
- 2 healthcare workforce lobbying pushes to watch
- States with the most, least SNF deficiencies
- Why CMS is quietly watching 8,600 physicians
- How a critical access hospital raised its cash on hand from 3 to 25 days
- USOP names regional ASC operations director
- Jefferson Health CDIO: How AI can take a workforce from great to phenomenal
- The math on physician pay is breaking down as reimbursements outpace compensation
- Illinois enacts law shielding abortion records from out-of-state entities
- 12 new behavioral health projects to know
- 5 numbers defining the pharmacy staffing crisis
- Lawsuit alleging mismanagement of UnitedHealth 401(k) forfeitures moves forward
- 2 most common CMS citations at psychiatric residential facilities
- 3 anesthesiologist assistant training programs to know
- PDS Health ranked among most community-minded companies
- The expense dominating ASCs’ budgets in 2026
- The pediatric behavioral health gap we can’t staff our way out of
- McLeod Regional unveils pediatric EmPATH unit
- Borland Groover to open new outpatient GI office
- Mercy opens $52M GI institute in Oklahoma City
- Cardiology APPs are taking over leadership roles: Report
- The states where ASCs are disappearing
- Colorado dental benefit caps, rate cuts to go into effect July 1: 4 notes
- Air Force Outbreak Grows As Military Reinstates Flu-Shot Rule For Recruits
- Maryland expands pharmacist scope to include opioid use disorder treatment
- Bayer scores landmark victory as Supreme Court overturns Roundup verdict
- GLP-1 Weight-Loss Boom Linked To Surge In Poison Control Calls
- Upside secures $20M series A to expand healthcare-focused housing platform
- Very Few Men Discuss Prostate Cancer Screening With Their Doctor
- Brain Scans Improve Targeting Of Magnetic Stimulation For Depression
- FDA shines harsh light on Pinnacle after finding fault with photodynamic therapy videos
- Estrogen Birth Control May Protect Women’s Brains As They Age
- Severe Pregnancy Nausea Tied To Higher Risk Of Complications
- Merck KGaA throws down $11.3B for Bio-Techne in its biggest deal since 2015 Sigma-Aldrich buy
- A Ban Won't Stop Abortion Pill Access, Telehealth Providers Say
- Opioid Settlement Money Pays for Services To Battle Addiction in Rural Kentucky
- Democrats To Propose Bill Capping Out-of-Pocket Medicare Costs for Enrollees
- Jubilant HollisterStier gets FDA warning letter for quality control problems
- Ionis scores transformational FDA label expansion for Tryngolza
- AstraZeneca spells out a community cancer screening strategy with the YMCA
- Novartis teams up with Becoming rentABLE for its new SMA campaign
- Penn Medicine crisis center cuts psychiatric ED consults 80% in 6 months
- Maryland extends behavioral health provider enrollment halt
- TGH Behavioral Health launches partial hospitalization program
- Preventing employee cynicism in a DSO
- Ohio dentist to pay $500,000 to resolve False Claim Act allegations
- 3 Washington dental offices pay $1M to settle Medicaid fraud allegations
- Illinois behavioral health CEO charged in $75M Medicaid fraud case
- Assort Health scores $120M series C to scale voice AI agent platform for healthcare
- Kaiser Health Plan ordered to pay hospital $82M over insufficient reimbursement
- Dentistry’s highest-paid CEO
- TigerConnect expands AI-driven platform with new scheduling capabilities
- US health spending set to reach $9T by 2034: CMS report
- Trial set for man accused of dental office shooting
- Vitana Pediatric & Orthodontic Partners expands capital structure with new financing partner
- Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO chief
- Senators call for $50B rural health fund to better target small providers, relax spending restrictions
- First Stop Health expands weight management program, shares first-year results
- Florida AG to probe CVS for anticompetitive pharmacy practices
- Pfizer scores 1st expansion in 7 years for breast cancer blockbuster Ibrance
- UnitedHealth, Humana And CVS Denied Post-Hospital Care At Some Of The Highest Rates
- Infinitus launches risk detection system to ensure appropriate patient triage from AI agents
- Even 5-Minute Movement Breaks Can Boost Your Mood And Fight Fatigue
- Lilly exec says MFN will affect company's obesity pill launch strategy in Europe: report
- Stada, under new CapVest ownership, picks up horde of European consumer brands
- Belly Laughs Spring From The Primitive Brain, Researchers Say
- Mom's Good Heart Health Lowers Risk Of Baby's Developmental Delays
- Accelerated Aging May Explain Rising Cancer Risk In Young Adults
- Coval raises $28M series A to address AI voice agent reliability, compliance
- Amid safety concerns, ADC Therapeutics plots 17% staff cuts to push resources behind Zynlonta
- Racial Gaps Narrow For U.S. Cancer Deaths, Report Finds
- Medicare's AI Push Snarls Patients And Doctors In Errors And Delays
- Even in Blue States, Hospitals Have Continued To Drop Gender-Affirming Care for Youths
- Patients prefer healthcare providers' AI agents to public chatbots, with human oversight non‑negotiable, survey finds
- Revance taps dancer Julianne Hough to choreograph social media push for Botox rival
- Western University opens multidisciplinary dental clinic
- Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing
- Some life insurers compete with health insurers on benefits. Here's why
- DOJ announces $6.5B healthcare fraud takedown with record Medicaid enforcement
- Locum tenens coverage becoming ‘more purposeful’ staffing strategy: Definitive Healthcare
- Testosterone Therapy Labels And Limits May Change Under FDA Proposal
- Unpacking CMS' decision to recalculate 2026 MA star ratings after Clover Health ruling
- Michigan hospitals denounce legislation to cap prices, limit mergers
- Incyte drops lawsuit as CMS relents on classification of Opzelura
- Medicare’s AI push snarls patients and doctors in errors and delays
- Midlife Strength Training Linked to Lower Diabetes Risk
- Badges, bots and blind spots
- Cadence secures $100M series C to advance AI-powered care for chronic disease
- Patient Portal Messages Double, Doctors Face Rising Workload
- Most Americans Unaware Of Link Between Alcohol And Cancer — And Aren't Interested In Spreading The Word, Either
- Sunscreen Misinformation Popular On TikTok, Study Finds
- Indiana Takes On Powerful Hospitals By Capping Prices They Charge Employers
- Kids’ Juice And Soda Intake Linked To Higher Blood Pressure Risk As Young Adults
- Medicare’s AI Push Snarls Patients and Doctors in Errors and Delays
- Worried About Your Aging Parents? Welcome to the Caregiving Club
- Hallmark Health Care Solutions launches AI solution to tackle workforce ‘black box’
- AdvanCell locks in lease for US headquarters, radiopharmaceutical production near Boston
- Novartis’ ‘Relax Your Tight End’ prostate cancer campaign wins Cannes Lions Pharma Grand Prix
- Whistleblower suit accuses Genentech, Novartis of running decades-long kickback scheme on allergy med Xolair
- Big obesity bets and China's rise fuel potential $2T in 2032 drug sales: Evaluate
- Clover Hill Dairy Recalls All Cheese in Deadly Listeria Outbreak
- Half of U.S. adults can't afford healthcare, Gallup poll finds
- Middle-Aged Women Drink More, Know Less About Breast Cancer Risk
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- CARsgen makes history as China approves world's first CAR-T therapy for solid tumors
- High Hurdles Thwart Kidney Patients' Pursuit Of Life-Saving Transplants
- Rising Healthcare Costs Leave Many Americans Less Secure
- Short Videos Help First-Time Dads Learn Newborn Safety Basics
- Federal Push To Increase U.S. Primary Care Docs Has Fizzled, Study Says
- US to investigate Germany's proposed drug spending reforms
- Alnylam scolded over promotional activity after Pfizer complaint
- They're Uninsured After Obamacare Became Too Costly. And They're Far From Alone.
- Indiana Takes On Powerful Hospitals by Capping Prices They Charge Employers
- Eli Lilly, Novo Nordisk top AI citation share as new report questions DTC spend culture
- Fish Oil Supplements May Be A Bust For Alzheimer's Prevention
- Prehab Can Boost Seniors' Recuperation From Spinal Fusion Surgery, Trial Finds
- Dog Owners Feel Similar Grief Whether Pets Euthanized, Die Naturally
- Ozempic Might Cut Risk Of Broken Bones, Study Says
- Massage Guns Can Cause Eye Damage, Vision Loss, Case Report Warns
- Ebola Infections Climb, Could Take Year To Contain, Health Officials Say
- Feeling Sleepy During the Day? It Could Be a Warning Sign for High Blood Pressure
- Major League Pitchers Might Avoid Elbow Injuries By Altering Their Approach, Simulation Suggests
- Birth Control Pills Might Increase Binge Eating Risk, Study Finds
- Women Might Lower Their Heart Risk By Lifting Weights, Study Says
- Personalized Brain Implant Provides Step-By-Step Walking Boost For Parkinson's Patients
- Most Americans Are Surviving Cancer. But The Mental Health Challenges Can Persist.
- Arrests of Immigrant Parents Create Mental Health Crisis for Children
- Sandwiched Between Caring for Kids and Aging Parents? Reach Out for Resources
- Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war
- Tennessee Pharmacies Sell Potent Ivermectin, Led by Anti-Vaccine Doctor Who’s Taken ‘Bucketloads’
- Democrats Seek To Spotlight Rising Health Costs by Forcing Vote on Trump Regulation
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
Michigan healthcare freedom community forum
Walgreens Boots Alliance Inc. has been supporting their stores with pharmacy profits as they lose a lot of money on their other retail lines. This bodes ill for controlling prescription drug costs in America, and will further challenge inner city residents seeking to fill their prescriptions:
Walgreens plans to close 1,200 stores as it looks for a turnaround
Walgreens’ stock has been hammered this year as consumer shopping patterns have changed, but the company’s latest earnings are getting better reception
By Emily Bary - October 15, 2024Walgreens Boots Alliance Inc. plans to shutter about 1,200 stores over the next three years in a bid to improve earnings.
The retail and pharmacy chain has struggled in recent years as shopping preferences have changed and consumers have moved to buy more products online. Walgreens previously embarked on a cost-cutting plan largely targeting the retail pharmacy business.
Walgreens announced the three-year plan for store closures alongside its earnings Tuesday morning, with the company noting that about 500 of the closures are expected in fiscal year 2025, which just began.
The company expects the move will prove immediately accretive to adjusted earnings per share and free cash flow.
After a deeply disappointing report three months back that brought a guidance cut and ushered in a 22% one-day stock decline, Walgreens’ latest results are getting a better reception on Wall Street. Shares are up 5% in premarket action Tuesday as Walgreens cleared the consensus view on both revenue and earnings.
The results “reflected our disciplined execution on cost management, working capital initiatives and capex reduction,” Chief Executive Tim Wentworth said in a release.
Walgreens’ revenue rose 6% to $37.5 billion, while analysts were looking for $35.8 billion.
The company’s U.S. retail pharmacy business saw a 6.5% sales gain in the quarter as well as an 8.3% rise in comparable sales. Pharmacy sales were up 9.6%, or 11.7% on a comparable-sales basis, reflecting “higher brand inflation and mix impact,” according to Walgreens’ earnings release.
Retail sales fell 3.5%, while comparable retail sales were down 1.7%, “reflecting a challenging retail environment and continued channel shift,” Walgreens said.
The company posted a fiscal fourth-quarter net loss of $3.0 billion, or $3.48 a share, compared with $180 million, or 21 cents a share, in the year-earlier period. The sizable loss included multiple non-cash charges.
On an adjusted basis, Walgreens earned 39 cents a share, while analysts tracked by FactSet were modeling 36 cents a share.
For fiscal 2025, Walgreens models $1.40 to $1.80 in adjusted earnings per share, while the FactSet consensus was for $1.72. The company expects its U.S. healthcare business and international business to grow, while the U.S. retail pharmacy business is anticipated to decline. The company is also looking for $147 billion to $151 billion in fiscal 2025, sales, while analysts were modeling $147.6 billion.
“Fiscal 2025 will be an important rebasing year as we advance our strategy to drive value creation,” Wentworth said. “This turnaround will take time, but we are confident it will yield significant financial and consumer benefits over the long term.”
Walgreens shares are down 66% so far this year.
NPR reporter Alina Selyukh has posted a backgrounder on the troubles at CVS and Walgreen's:
https://www.npr.org/2024/10/16/nx-s1-5154129/cvs-and-walgreens-closing-stores-why
CVS and Walgreens are ailing. Here’s why
By Alina Selyukh - October 16, 2024Not too long after Tim Wentworth became CEO of Walgreens, he revealed a stunning figure: Roughly a quarter of the pharmacy chain’s stores do not make money.
On Tuesday, he said 1,200 of those stores will close over three years. That’s two weeks after rival CVS announced layoffs of 2,900 corporate staff. Both chains are on a multibillion-dollar cost-saving spree — closing hundreds of locations, cutting thousands of jobs and, really, reconsidering their role in Americans’ lives.
The slow simmer of mistakes and misfortunes has come to a boil for the biggest U.S. drugstore chains. They’ve accumulated too many stores at a time of changing shopper habits. They’re saddled with numerous government fines and a particularly ailing relationship with health insurers.
The problem of stores
CVS and Walgreens have some notable differences. Walgreens, which also owns the British drugstore Boots, is more singularly focused on its pharmacy business. CVS has expanded further into health care through mergers with insurer Aetna and Caremark, a pharmacy benefit manager that helps insurers negotiate prescription drug coverage and costs. Yet the two companies have made similar missteps.
The simplest part of the problem is scale. CVS and Walgreens grew massive nationwide footprints of more than 9,000 and 8,000 stores, respectively. They gobbled up mom-and-pop shops and signed long-term leases for prime locations on street corners.
Now, shoppers regularly complain about chronically understaffed stores, with products locked up to prevent theft. The shelves of snacks, makeup, greeting cards and cleaning products were meant to boost profits. But sales have sagged for years — a result of a losing battle with Amazon, Walmart, Costco, grocery and dollar stores.
CVS and Walgreens “probably do have too many stores because they overexpanded, but the bigger problem is that the stores that they have are not very good,” said Neil Saunders, retail analyst at the firm GlobalData.
The chains have failed to add new incentives for shoppers, beyond photo booths and returns drop-off centers, says Anshuman Jaiswal, a longtime consultant to retailers and pharmacies. And neither chain has built a meaningful online presence designed to give customers what they need.
“If you go to CVS.com or Walgreens.com, if you are placing an order for cough syrup, why don't I sell chicken broth as a product recommendation immediately?” Jaiswal says. “It's about reimagining the business model.”
The problem of prescriptions
Given the retail struggles, pharmacies could perhaps simply ditch the convenience store and focus on selling medicine — except CVS and Walgreens say it’s harder and harder to make a profit from this part of their business.
Years ago, a big shift in the power balance between pharmacies and health insurers revealed the limits of drugstores’ leverage.
“Historically, there was a view that there was a lot of customer loyalty to their specific retail pharmacy … and that patients, or consumers, would be all up in arms if they were forced to move their prescriptions,” says Brian Tanquilut, health care services analyst at the investment bank Jefferies.
Walgreens tested this theory about a decade ago when it got into a public fight with Express Scripts, a pharmacy benefit manager that worked with major health insurers.
Walgreens and Express Scripts played a game of chicken over how much Walgreens should earn from prescriptions — and Walgreens lost. For a time, it got kicked out of insurance networks used by millions of people, who simply went elsewhere to get their medicine at the lower in-network prices.
“What that did was to prove that patient loyalty is not to the retail pharmacy, but it actually is whatever my insurance is willing to pay,” Tanquilut says. “And that opened the door for the payers to keep pushing pricing down on retail pharmacy chains.”
Hoping reinvention is the cure
These days, CVS and Walgreens are facing tough competition from pharmacies that don’t depend as much on profits from prescriptions because they’re part of retail giants, including Walmart and Costco. The drugstore chains also have spent millions of dollars on government fines over allegations of unsafe staffing levels, overbilling government insurance programs and contributing to the opioid epidemic.
Over the years, CVS and Walgreens attempted to reframe themselves as health care hubs, expanding primary-care clinics. But these operations cost time and money.
On Tuesday, Walgreens CEO Wentworth said his chain is “reorienting to its legacy strength as a retail pharmacy-led company.” CVS is reportedly weighing a breakup to undo its mergers with Aetna and Caremark.
Both companies are also proposing new structures for how they want to be paid for filling prescriptions, hoping this is the big shot in the arm they need.
"I'm very confident that over a two- to three-year period we will have reset the framework for reimbursement discussions," Wentworth told investors on Tuesday. “We are in the early stages of a turnaround that will take time.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.























